Autor: "Hammer AE" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study.
Autorzy:: Fakhoury TA
Miller JM
Hammer AE
Vuong A; Pokaż więcej
Źródło:: Drugs & Aging; 2008, Vol. 25 Issue 11, p955-962, 8p

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs.
Autorzy:: Miller JM
Kustra RP
Vuong A
Hammer AE
Messenheimer JA; Pokaż więcej
Źródło:: Drugs; 2008, Vol. 68 Issue 11, p1493-1509, 17p

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab.
Autorzy:: Roth DA; Research and Development, GlaxoSmithKline, Philadelphia, PA, USA .
Thompson A; Research and Development, GlaxoSmithKline, Research Triangle Park, NC, USA.
Tang Y; Research and Development, GlaxoSmithKline, Research Triangle Park, NC, USA.
Hammer AE; Research and Development, GlaxoSmithKline, Research Triangle Park, NC, USA.
Molta CT; Research and Development, GlaxoSmithKline, Philadelphia, PA, USA.
Gordon D; Research and Development, GlaxoSmithKline, Philadelphia, PA, USA.; Pokaż więcej
Źródło:: Lupus [Lupus] 2016 Apr; Vol. 25 (4), pp. 346-54. Date of Electronic Publication: 2015 Sep 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibodies, Monoclonal, Humanized/*therapeutic use
B-Cell Activating Factor/*blood
Immunosuppressive Agents/*therapeutic use
Lupus Erythematosus, Systemic/*blood
Lupus Erythematosus, Systemic/*drug therapy
Adult ; Antibodies, Monoclonal, Humanized/adverse effects ; B-Cell Activating Factor/immunology ; Biomarkers/blood ; Chi-Square Distribution ; Disease Progression ; Female ; Humans ; Immunosuppressive Agents/adverse effects ; Logistic Models ; Lupus Erythematosus, Systemic/diagnosis ; Lupus Erythematosus, Systemic/immunology ; Male ; Middle Aged ; Odds Ratio ; Predictive Value of Tests ; Proportional Hazards Models ; Risk Factors ; Time Factors ; Treatment Outcome ; Up-Regulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Long-term tolerability and safety of lamotrigine extended-release: pooled analysis of three clinical trials.
Autorzy:: Biton V; Arkansas Epilepsy Program, Little Rock, AR 72205, USA. />Shneker BF
Naritoku D
Hammer AE
Vuong A
Caldwell PT
Messenheimer JA; Pokaż więcej
Źródło:: Clinical drug investigation [Clin Drug Investig] 2013 May; Vol. 33 (5), pp. 359-64.
Typ publikacji:: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms:: Anticonvulsants/*therapeutic use
Seizures/*drug therapy
Triazines/*therapeutic use
Anticonvulsants/administration & dosage ; Anticonvulsants/adverse effects ; Chemistry, Pharmaceutical ; Delayed-Action Preparations ; Double-Blind Method ; Drug Administration Schedule ; Humans ; Lamotrigine ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Seizures/diagnosis ; Seizures/physiopathology ; Time Factors ; Treatment Outcome ; Triazines/administration & dosage ; Triazines/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Hammer AE"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język